Related Experiment Videos

[Hereditary angioedema: changes in serum levels of C4 in response to danazol]

J Egidio Fabiani1, L Squiquera, J Leoni

  • 1Instituto Argentino de Alergia e Inmunología.

Insights

Danazol treatment improved complement levels in hereditary angioedema (HAE) patients. Complement component C4 and C1 inhibitor (C1-INH) levels increased, resolving circulating immune complexes (CIC).

Area of Science:

  • Immunology
  • Complement System Biology

Context:

  • Hereditary Angioedema (HAE) is a rare genetic disorder.
  • Complement system dysregulation is implicated in HAE pathogenesis.

Purpose:

  • To evaluate the effect of Danazol on complement levels in HAE patients.
  • To investigate the relationship between complement components and circulating immune complexes (CIC).

Summary:

  • Twelve HAE patients received 400 mg/day of Danazol for 10 days.
  • Treatment led to the disappearance of CIC and significant increases in C4, C1-inhibitor (C1-INH), Cls, and CH50 levels.
  • C4 levels showed a more rapid increase than C1-INH.

Impact:

  • Suggests a potential primary defect in C4 synthesis in some HAE patients with CIC.
  • Postulates Danazol may stimulate C4 synthesis, offering a therapeutic insight for HAE management.

Related Concept Videos